Catherine S Yao, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Yao’s office at (888) 334-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A119644 · Current
Licensed to practise in California · since 2012 · expires 2028-01-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatrics
Medicaid work
$9,753 in 2024
Medicaid paid $9,753 for 2,461 billed services this clinician did in 2024, up to 50 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 484 | $3,886 |
| Return visit (30+ min) | 130 | $1,675 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 15 | $1,265 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 27 | $695 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 17 | $680 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 14 | $329 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 26 | $254 |
| Developmental screening | 60 | $240 |
| Screening test, pure tone, air only | 162 | $239 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 60 | $116 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 82 | $114 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 303 | $72 |
| 2024 | 2,461 | 26 | 50 | $9,753 |
| 2023 | 2,212 | 21 | 62 | $3,792 |
| 2022 | 1,058 | 20 | 70 | $2,888 |
| 2021 | 3,008 | 23 | 85 | $8,232 |
| 2020 | 1,903 | 19 | 67 | $5,175 |
| 2019 | 1,343 | 21 | 80 | $7,442 |
| 2018 | 3,168 | 28 | 106 | $21,505 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 538 | $2,050 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 13 | $520 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 15 | $397 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 118 | $346 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 103 | $149 |
| Screening test, pure tone, air only | 196 | $110 |
| Return visit (30+ min) | 12 | $103 |
| Developmental screening | 15 | $60 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 170 | $33 |
| HEMOGLOBIN | 112 | $15 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 12 | $9 |
| Puncture of skin for collection of blood sample | 209 | $0 |
2022
| Short return visit (20+ min) | 301 | $1,428 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 15 | $547 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose | 17 | $280 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 27 | $231 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 26 | $116 |
| Developmental screening | 17 | $60 |
| Screening test, pure tone, air only | 74 | $55 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 15 | $45 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 106 | $45 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 15 | $45 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 13 | $33 |
| HEMOGLOBIN | 13 | $3 |
2021
| Short return visit (20+ min) | 647 | $3,857 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 50 | $2,082 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 73 | $812 |
| Return visit (30+ min) | 35 | $348 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 71 | $346 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 30 | $126 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 39 | $126 |
| Screening test, pure tone, air only | 190 | $121 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 27 | $108 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 154 | $90 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 263 | $68 |
| HEMOGLOBIN | 161 | $50 |
2020
| Short return visit (20+ min) | 393 | $2,990 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 24 | $725 |
| Return visit (30+ min) | 27 | $410 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 60 | $346 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 68 | $232 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 146 | $126 |
| Screening test, pure tone, air only | 159 | $99 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 26 | $72 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 25 | $72 |
| HEMOGLOBIN | 151 | $33 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 12 | $27 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 79 | $25 |
2019
| Short return visit (20+ min) | 511 | $3,068 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 40 | $1,449 |
| Return visit (30+ min) | 49 | $921 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 44 | $692 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 74 | $580 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 42 | $253 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 155 | $133 |
| Screening test, pure tone, air only | 79 | $110 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 32 | $81 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 16 | $54 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 12 | $36 |
| HEMOGLOBIN | 114 | $19 |
2018
| Short return visit (20+ min) | 1,088 | $7,997 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 144 | $4,879 |
| Return visit (30+ min) | 243 | $3,374 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 186 | $1,738 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 68 | $1,083 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 136 | $911 |
| Screening test, pure tone, air only | 195 | $320 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 103 | $279 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 157 | $159 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 46 | $126 |
| Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use | 28 | $99 |
| Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 39 | $72 |
Money from drug and device companies
$112 in 2024
| 2024 | 1 | 1 | None | $112 |
| 2020 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| kaleo | Auvi-Q | $112 | 1 payment
|
See the published payment
| kaleo | Meals · 2024-03-26 | Auvi-Q | $112 |
See earlier years (2020)
2020: $23
| Zimmer Biomet Holdings | All T3 Implants | $23 | 1 payment
|
Professional record
- NPI
- 1801166442
- Licence
- CA A119644California A119644: Current · expires 2028-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 750 South Bascom Avenue, San Jose, CA, 95128
- NPI first listed
- 2012-01-12
- NPI last updated
- 2013-07-10
This is when the NPI record was last certified, not a medical board exam.